Elevated Serum Lipoprotein (a) Levels Associated with Ulcerative Colitis in a Young Japanese Patient

Internal Medicine

Volumn 36, Issue 6, 1997, Pages 389-391

  Kawabata, Shigeharu ^a   Katagiri, Shuichi ^a   Negoro, Hiroshi ^a   Nogami, Akira ^a   Yabuuchi, Iwao ^a   Gomi, Masahiro ^a   Arima, Ryoichi ^a   Tarui, Seiichiro ^a  

^a Otemae Hospital   (Japan)

Author keywords

Hyper Lp(a) emia; Hypercoagulation; Inflammatory bowel disease (IBD); Lipoprotein (a) Lp(a) ; Prothrombotic state; Small vessel thrombosis; Small vessel thrombus

Indexed keywords

LIPOPROTEIN A;

ADULT; ARTICLE; BLOOD; CASE REPORT; GENETICS; HUMAN; HYPERLIPOPROTEINEMIA; MALE; PATHOLOGY; PHENOTYPE; RECTUM; THROMBOEMBOLISM; ULCERATIVE COLITIS; VASCULARIZATION;

ADULT; COLITIS, ULCERATIVE; HUMANS; HYPERLIPOPROTEINEMIAS; LIPOPROTEIN(A); MALE; PHENOTYPE; RECTUM; THROMBOEMBOLISM;

EID: 0031155909     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.389     Document Type: Article

References (18)

1. Bargen JA, Barker NW. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 58: 17, 1936.
2. Ricketts WE, Palmer WL. Complications of chronic nonspecific ulcerative colitis. Gastroenterology 7: 55, 1946.
3. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 5: 1, 1964.
4. Wakefield AJ, Sawyerr AM, Dhillon AP. et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 2: 1057, 1989.
5. Scanu AM, Fless GM. Lipoprotein (a). Heterogeneity and biological relevance. J Clin Invest 85: 1709, 1990.
6. Edwards RL, Levine JB, Green R. et al. Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity. Gastroenterology 92: 329, 1987.
7. Webberley MJ, Hart MT, Melikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut 34: 247, 1993.
8. Graef V, Baggenstoss AH, Sauer WG, Spittell JA, Minn R. Venous thrombosis occurring in nonspecific ulcerative colitis. Arch Intern Med 117: 377, 1966.
9. Talbot RW, Heppell J, Dozois RR, Beart RW Jr. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 61: 140, 1986.
10. Berg K. A new serum type system in man - the Lp system. Acta Pathol Microbiol Scand 59: 369, 1963.
11. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Qunici GB. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 38: 51, 1981.
12. Armstrong VW, Cremer P, Eberle E. et al. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis 62: 249, 1986.
13. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM Jr. Association of levels of lipoprotein (a) Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 74: 758, 1986.
14. Mclean JW, Tomlinson JE, Kuang WJ. et al. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 330: 132, 1987.
15. Harpel PC, Gordon BR, Parker TS. Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin. Proc Natl Acad Sci USA 86: 3847, 1989.
16. Loscalzo J, Weinfeld M, Fless GM, Scanu AM. Lipoprotein (a), fibrin binding, and plasminogen activation. Arteriosclerosis 10: 240, 1990.
17. Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risks associated with lipoprotein (a). Nature 339: 301, 1989.
18. Hajjar KA, Gavish D, Breslow JL, Nachman RL. Lipoprotein (a) modulation of endothelial cell surface tibrinolysis and its potential role in atherosclerosis. Nature 339: 303, 1989.